Comprehensive Program for Disease Management in Heart Failure Patients in the Community
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Heart Failure
- Sponsor
- Sheba Medical Center
- Enrollment
- 1360
- Locations
- 1
- Primary Endpoint
- hospital admissions for heart failure or all-cause mortality
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The purpose of this study is to determine whether a nurse-led, comprehensive disease management program is effective in reducing recurrent hospital admissions and deaths in community dwelling patients with moderate to severe heart failure.
Detailed Description
Heart failure remains a significant cause of death, in spite of recent declines in overall mortality from cardiovascular disease. Heart failure is associated with increasing costs for healthcare, mainly for recurrent hospital admissions. Disease management programs aimed to improve patients outcome while containing healthcare costs,were employed in heart failure patients with varying results. Such programs contain various components, including patient education and empowerment, monitoring patients' adherence to therapy, telemonitoring of vital parameters, etc. Designated heart failure clinics were also employed in care given to these patients.
Investigators
Ofra Kalter-Leibovici MD
Dr. Ofra Kalter-Leibovici
Maccabi Healthcare Services, Israel
Eligibility Criteria
Inclusion Criteria
- •Adult patients with NYHA-Stage III-IV heart failure recruited in the community;
- •Adult patients with NYHA-Stage II-IV heart failure recruited after hospital admission for decompensated heart failure
Exclusion Criteria
- •Other severe disease (e.g. end stage renal disease, metastatic cancer); bedridden or severely compromised functional status due to other diseases; drug or alcohol abuse; Severe cognitive impairment; People unconnected to telephone
Outcomes
Primary Outcomes
hospital admissions for heart failure or all-cause mortality
Time Frame: 5 years
Secondary Outcomes
- Health-related Quality of Life;(5 years)
- Functional status(5 years)